Investigating Risk-Based Treatment Strategies for Pediatric Non-Rhabdomyosarcoma Soft-Tissue Sarcoma
OncLive,
Robert Lawrence Randall, MD, FACS A phase 3 trial (NCT00346164; ARST 0332) is investigating risk-based treatment strategies for…
A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study
Overview of attention for article published in Lancet Oncology, November 2019
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (93rd percentile)
-
Above-average Attention Score compared to outputs of the same age and source (64th percentile)
Readers on
- mendeley
- 145 Mendeley